Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Allergic Reactions: Anaphylaxis

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

Hypersensitivity Reactions: Cytolytic Reactions

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...

Drug toxicity: Idiosyncratic Reactions

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

Allergic Reactions

Allergic Reactions

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The utility of miR-16, miR-146a and miR-155 in serum and urine for juvenile idiopathic arthritis diagnostics and monitoring.

Pediatric rheumatology online journal·2025

Same author

Adverse Drug Reactions in an Intensive Care Unit of a Secondary Care Lithuanian Hospital: A Prospective Observational Study.

Healthcare (Basel, Switzerland)·2025

Same author

Trends in adverse drug reaction reporting in eight selected countries after the implementation of new pharmacovigilance regulation in 2012: a joinpoint regression analysis.

European journal of clinical pharmacology·2025

Same author

Drugs Metabolism-Related Genes Variants Impact on Anthracycline-Based Chemotherapy Induced Subclinical Cardiotoxicity in Breast Cancer Patients.

International journal of molecular sciences·2025

Same author

Comparing immunogenicity and safety following transition from reference rituximab to biosimilar rituximab (DRL_RI) in patients with rheumatoid arthritis: a randomized, double-blind, phase 3 study.

Arthritis research & therapy·2024

Same author

The importance of ultrasound examination in care of juvenile idiopathic arthritis patients: 9 months follow-up study.

Frontiers in pediatrics·2024

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Severe vancomycin-induced anaphylactic reaction.

Rūta Kupstaite¹, Asta Baranauskaite, Margarita Pileckyte

¹Department of Theoretical and Clinical Pharmacology, Kaunas University of Medicine, Kaunas, Lithuania. e610614@yahoo.com

Medicina (Kaunas, Lithuania)

|March 18, 2010

Summary

Vancomycin treats methicillin-resistant Staphylococcus aureus infections but can cause severe side effects. This case highlights a rare anaphylactic reaction to vancomycin in a young man.

Related Experiment Videos

Last Updated: Jun 15, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Area of Science:

Pharmacology
Infectious Diseases
Clinical Medicine

Background:

Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Despite its efficacy, vancomycin is linked to various adverse effects, ranging from nephrotoxicity and ototoxicity to hypersensitivity reactions.
Two distinct hypersensitivity reactions are recognized: Red Man Syndrome (anaphylactoid) and true anaphylaxis.

Observation:

A 23-year-old male patient was undergoing treatment for a methicillin-resistant Staphylococcus aureus infection.
The patient developed a severe hypersensitivity reaction during vancomycin therapy.
The observed reaction was consistent with anaphylaxis.

Findings:

The patient experienced a vancomycin-induced anaphylactic reaction.
This case underscores the potential for severe, life-threatening hypersensitivity to vancomycin.
Distinguishing anaphylaxis from Red Man Syndrome is crucial for appropriate clinical management.

Implications:

Clinicians must maintain a high index of suspicion for anaphylaxis in patients receiving vancomycin.
Prompt recognition and management of vancomycin-induced anaphylaxis are essential for patient safety.
Further research into the mechanisms and prevention of vancomycin hypersensitivity may be warranted.